Literature DB >> 10406589

Histological observations and the process of ultrasound contrast agent enhancement of tissue plasminogen activator thrombolysis with ultrasound exposure.

I Kondo1, K Mizushige, T Ueda, H Masugata, K Ohmori, H Matsuo.   

Abstract

Although the enhancement of tissue plasminogen activator (tPA) induced thrombolysis by ultrasound has been reported to be augmented by ultrasound contrast agents (UCA), few data exist regarding its process. The present study evaluated the effect of a galactose based UCA on the efficacy of ultrasonic enhancement of tPA thrombolysis and observed the serial changes in the acoustic property and histopathology. A catheter-type transducer capable of ultrasound emission in both continuous (CW) and pulsed wave (PW) was used. The tPA thrombolysis was studied in 30 artificial white thrombi, which were assigned to 4 study groups based on insonation modes and with and without UCA. Each sample was suspended in 100ml saline in a beaker. Five minutes after tPA (8000U) administration, ultrasound was applied for 10min. For the UCA-treated groups, UCA (0.25g) was added 5 min after the start of ultrasound exposure. The alteration of the thrombus was monitored with echography. Weight reduction of the thrombus was -25+/-6% in PW and -30+/-7% in CW, which was significantly enhanced by UCA treatment, 40+/-3% (p<0.005) in PW+UCA and -43+/-7% (p<0.005) in CW+UCA. The area of thrombus echo image minimally decreased with ultrasound alone (-12+/-6%: PW, -23+/-11%: CW). In the UCA groups, UCA induced a remarkable reduction of size (-36+/-3%: PW+UCA, -43+/-7%: CW+UCA) with a high-echo intensity in the superficial layer of the thrombus, where multiple cavity formation was observed by light microscope. UCA markedly enhanced the effect of ultrasound on tPA thrombolysis. The altered acoustic property and corresponding histological microcavity formation in the shallow layer within the thrombus suggests that UCA augmented infiltration of tPA into the thrombus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10406589     DOI: 10.1253/jcj.63.478

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  8 in total

Review 1.  Sonothrombolysis.

Authors:  Kenneth B Bader; Guillaume Bouchoux; Christy K Holland
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 2.  Role of transcranial Doppler ultrasonography in evaluation of patients with cerebrovascular disease.

Authors:  Vijay K Sharma; Georgios Tsivgoulis; Annabelle Y Lao; Andrei V Alexandrov
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 3.  Role of transcranial Doppler ultrasonography in acute stroke.

Authors:  Vijay K Sharma; N Venketasubramanian; Dheeraj K Khurana; Georgios Tsivgoulis; Andrei V Alexandrov
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.714

4.  Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Authors:  Azita Soltani; Wayne M Clark; Douglas R Hansmann
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

5.  Recanalization therapies in acute ischemic stroke: pharmacological agents, devices, and combinations.

Authors:  Vijay K Sharma; Hock Luen Teoh; Lily Y H Wong; Jie Su; Benjamin K C Ong; Bernard P L Chan
Journal:  Stroke Res Treat       Date:  2009-12-09

6.  Tissue plasminogen activator concentration dependence of 120 kHz ultrasound-enhanced thrombolysis.

Authors:  George J Shaw; Jason M Meunier; Christopher J Lindsell; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2008-05-12       Impact factor: 2.998

7.  Therapeutic application of ultrasound: contrast-enhanced thrombolysis in acute ST-elevation myocardial infarction; the Sonolysis study.

Authors:  J Slikkerveer; G Veen; Y Appelman; N van Royen; O Kamp
Journal:  Neth Heart J       Date:  2011-03-08       Impact factor: 2.380

8.  Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: rationale and design of the Sonolysis study.

Authors:  Jeroen Slikkerveer; Pieter A Dijkmans; Gertjan T Sieswerda; Pieter A F M Doevendans; Arie P J van Dijk; Freek W A Verheugt; Thomas R Porter; Otto Kamp
Journal:  Trials       Date:  2008-12-10       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.